Switzerland· 00615001
Priorix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
A masern, kombinationen mit mumps und röteln, lebend abgeschwächt product containing virus morbilli vivus (stamm schwarz), virus parotitis vivus (stamm rit 4385), virus rubella vivus (stamm wistar ra 27/3), registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BD52 (masern, kombinationen mit mumps und röteln, lebend abgeschwächt), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt · ATC J07BD52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- virus morbilli vivus (Stamm Schwarz), virus parotitis vivus (Stamm RIT 4385), virus rubella vivus (Stamm Wistar RA 27/3)
- Manufacturer
- GlaxoSmithKline AG
- Country
- Switzerland (CH)
- ATC code
- J07BD52
- ATC class
- Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BD52
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt, as other registers publish it.
- CanadaM-M-R IIMERCK CANADA INC
- NorwayM-M-RvaxproMerck Sharp & Dohme B.V.
- DenmarkM-M-RvaxproMerck Sharp & Dohme B.V.
- DenmarkM-M-RvaxproMerck Sharp & Dohme B.V.
- FinlandM-M-RvaxproMerck Sharp & Dohme B.V.
- PolandM-M-RvaxProMerck Sharp & Dohme B.V.
- BelgiumM-M-RVaxProMerck Sharp & Dohme
- BelgiumM-M-RVaxProMerck Sharp & Dohme
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf2ff226-a372-45fd-b54a-ba533d2d8c5c GET /v1/drugs/cf2ff226-a372-45fd-b54a-ba533d2d8c5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Impfstoffe"
}See everything about masern, kombinationen mit mumps und röteln, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.